Bayer receives U.S. FDA Fast Track Designation for asundexian atrial fibrillation program
Berlin, May 16, 2023 – Bayer today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track ...
Read moreDetailsBerlin, May 16, 2023 – Bayer today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track ...
Read moreDetails10 May 2023 | 09:59 AM Europe/Amsterdam Not intended for U.S. and UK Media Summary Global phase III QUASAR study ...
Read moreDetails© 2023 earth-news.info
© 2023 earth-news.info